NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

SPDR S&P Biotech ETF logo
$145.88 -4.67 (-3.10%)
Closing price 04:10 PM Eastern
Extended Trading
$145.97 +0.09 (+0.06%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

Advanced

Key Stats

Today's Range
$145.50
▼
$151.34
50-Day Range
$144.32
▼
$163.81
52-Week Range
$113.06
▼
$169.89
Volume
11.47 million shs
Average Volume
9.17 million shs
Market Capitalization
$9.89 billion
Assets Under Management
$10.35 billion
Dividend Yield
0.37%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.55%0.57%0.50%0.53%
Other Expenses0.00%0.52%0.53%0.60%0.54%
Total Expense0.35%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.76%-0.67%
Net Expense0.35%0.58%0.63%0.57%0.60%
Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XBI ETF News Headlines

The warning signs most investors see too late
Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel
See More Headlines

XBI ETF - Frequently Asked Questions

SPDR S&P Biotech ETF's stock was trading at $121.93 on January 1st, 2026. Since then, XBI stock has increased by 20.2% and is now trading at $146.5660.

Top institutional shareholders of SPDR S&P Biotech ETF include Healthcare of Ontario Pension Plan Trust Fund (11.07%), Bessemer Group Inc. (0.98%), Annex Advisory Services LLC (0.40%) and Whittier Trust Co. (0.38%).

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Biotech ETF investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Invesco QQQ (QQQ), PayPal (PYPL) and SPDR S&P 500 ETF Trust (SPY).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
184

Fund Statistics

Assets Under Management
$10.35 billion
Average Daily Volume
$9.30 million
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
State Street Global Advisors Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
36,425
Put Options
12,126
Call Options
24,299
Short Interest
67,491,398 shs

Miscellaneous

Beta
0.87
Creation Unit
50,000
Creation Fee
$250.00
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Top 10 XBI Holdings

XBI Sector Exposure

XBI Industry Exposure


This page (NYSEARCA:XBI) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners